Medpace Holdings Inc. (MEDP) shares rose 6.4% to $662.48 on October 21, 2026, bringing their one-year gain to 21.4%.
Key Takeaways
- Insiders sold $467.0 million in shares over the preceding 12 months, with no purchases reported.
Table of Contents
Medpace shares approach the upper end of their annual range
The $662.48 price was below Medpace’s 52-week high of $677.90, following a year in which the shares traded as low as $373.00.
Medpace’s trailing price-to-earnings ratio stood at 38.9 times, compared with its five-year median of 31.5 times. The forward P/E was 34.4 times.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
